Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases

L Duan, X Li, R Ji, Z Hao, M Kong, X Wen, F Guan… - Polymers, 2023 - mdpi.com
Neurodegenerative diseases are common, incurable neurological disorders with high
prevalence, and lead to memory, movement, language, and intelligence impairments …

Peptides as pharmacological carriers to the brain: promises, shortcomings and challenges

S Parrasia, I Szabò, M Zoratti… - Molecular …, 2022 - ACS Publications
Central nervous system (CNS) diseases are among the most difficult to treat, mainly
because the vast majority of the drugs fail to cross the blood-brain barrier (BBB) or to reach …

Altered cholesterol homeostasis in Huntington's disease

R Kacher, C Mounier, J Caboche… - Frontiers in aging …, 2022 - frontiersin.org
Huntington's disease (HD) is an autosomal dominant genetic disorder caused by an
expansion of the CAG repeat in the first exon of Huntingtin's gene. The associated …

Biopolymer nanoparticles for nose-to-brain drug delivery: A new promising approach for the treatment of neurological diseases

N Montegiove, E Calzoni, C Emiliani… - Journal of Functional …, 2022 - mdpi.com
Diseases affecting the central nervous system (CNS) are among the most disabling and the
most difficult to cure due to the presence of the blood–brain barrier (BBB) which represents …

Focusing the pivotal role of nanotechnology in Huntington's disease: an insight into the recent advancements

S Singh, Hema, N Sharma, M Sachdeva, T Behl… - … Science and Pollution …, 2022 - Springer
Neurodegeneration is the loss of neuronal capacity and structure over time which causes
neurodegenerative disorders like Alzheimer, amyotrophic lateral sclerosis, Parkinson, and …

Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview

YH Song, R De, KT Lee - Advances in Colloid and Interface Science, 2023 - Elsevier
Blood-brain barrier (BBB) serves as an essential interface between central nervous system
(CNS) and its periphery, allowing selective permeation of ions, gaseous molecules, and …

Neuronal and astrocytic contributions to Huntington's disease dissected with zinc finger protein transcriptional repressors

MR Gangwani, JS Soto, Y Jami-Alahmadi, S Tiwari… - Cell reports, 2023 - cell.com
Huntington's disease (HD) is caused by expanded CAG repeats in the huntingtin gene (HTT)
resulting in expression of mutant HTT proteins (mHTT) with extended polyglutamine tracts …

The translational potential of cholesterol-based therapies for neurological disease

M Valenza, G Birolini, E Cattaneo - Nature Reviews Neurology, 2023 - nature.com
Cholesterol is an important metabolite and membrane component and is enriched in the
brain owing to its role in neuronal maturation and function. In the adult brain, cholesterol is …

[HTML][HTML] Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease

G Mustafa, D Hassan, M Zeeshan, G Ruiz-Pulido… - Journal of Drug Delivery …, 2023 - Elsevier
Huntington's disease (HD) is a neurological disorder characterized by a reduction in
medium-spiny neurons in the brain. Currently, there is no cure for HD and treatment relies …

Optimization of an injectable hydrogel depot system for the controlled release of retinal-targeted hybrid nanoparticles

I Ottonelli, A Bighinati, E Adani, F Loll, R Caraffi… - Pharmaceutics, 2022 - mdpi.com
A drawback in the development of treatments that can reach the retina is the presence of
barriers in the eye that restrain compounds from reaching the target. Intravitreal injections …